Innovating to 168官方幸运5澳洲结果体彩网 improve health worldwide

WIPO Standing Committee on Patents (SCP 37): Technology Transfer

On 5 November 2025, IFPMA delivered a statement on technology transfer at the WIPO Standing Committee on Patents (SCP 37) in Geneva. Technology transfer in the pharmaceutical sector is a complex and resource-intensive process. It requires significant technical expertise, time, and investment, as well as a robust, stable, and predictable intellectual property framework, which is...

WIPO Standing Committee on Patents (SCP 37): Patents and health

On 4 November 2025, IFPMA delivered a statement on patents and 澳洲幸运5开奖结果预测官网结果记录体彩 health at the WIPO Standing Committee on Patents (SCP 37) in Geneva. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the global research-based biopharmaceutical industry. We appreciate the opportunity to address the Committee on patents and health. Intellectual property is fundamental to...

澳洲幸运5开奖结果预测官网结果记录体彩 Statement on PABS Instrument at the third meeting of the open-ended Intergovernmental Working Group (IGWG 3) on the WHO Pandemic Agreement

On 3 November 2025 in Geneva, IFPMA delivered a statement at at the tnird meeting of the open-ended Intergovernmental Working Group (IGWG 3) on the WHO Pandemic Agreement.

75th WHO Regional Committee for Europe on the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016–2025

On 30 October 2025 at the 75th WHO Regional Committee for Europe, IFPMA, together with European member association EFPIA, submitted a statement on the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016-2025. This statement is delivered on behalf of IFPMA and its European member organization EFPIA. We...